×
<- Back

155841 - Driving Safety – Sedating Medications & Opioid Agonist Treatment

  • : Online

Prescribers and health professionals caring for patients who receive opioid agonist treatment (OAT) need to be aware of the potential impact of treatments and other factors on driving safety. 

For individuals receiving pharmacotherapy for the treatment of opioid dependence: 

Driving or operating heavy machinery after dosing with methadone or buprenorphine is not associated with increased risk of accident or injury provided the patient is on a stable dose of the medication and is not using significant amounts of other psychoactive drugs (particularly alcohol, benzodiazepines or cannabis). 

This short course is designed to support health professionals in assessing a patient’s fitness to drive, with a focus on sedating medications and OAT.

Relevance to General Practice

Driving a motor vehicle or operating heavy machinery is a complex task that requires sufficient sensory input, cognitive function, and motor function. A range of medical conditions, disabilities and treatments can impact on these tasks and may result in impairment. It is important that individuals and their health professionals are aware of the circumstances that makes someone unsuitable to drive, whether it be related to fitness to drive today, or fitness to hold a licence. 

For individuals receiving pharmacotherapy for the treatment of opioid dependence: 

Driving or operating heavy machinery after dosing with methadone or buprenorphine is not associated with increased risk of accident or injury provided the patient is on a stable dose of the medication and is not using significant amounts of other psychoactive drugs (particularly alcohol, benzodiazepines or cannabis). 

[NSW Clinical Guidelines: Treatment of Opioid Dependence (2018)]

Learning outcomes
  • Manage patient factors that can impact on driving safety & diagnose risks to driving, including for those receiving opioid agonist treatment (OAT).
  • Implement principles of short-term fitness to drive and long-term medical fitness to drive into daily patient assessment and practice.
  • Manage roles and responsibilities, confidentiality, and difficult clinical conversations to effectively manage patient fitness to drive for patients.
  • Implement the medical standards for licensing and reporting legislation within New South Wales into practice.
  • Delivery
    Title
    155841 - Driving Safety – Sedating Medications & Opioid Agonist Treatment
    Location
    Provider Type
    Education Provider
    Duration
    1 hour
    Start Date
    22-Apr-2019
    End Date
    31-Dec-2019
    CPD
    1 hour
    Price
    0.00
    Location
    Online
    Contact Phone
    Log in into view this field.
    11 Views
    Similar Courses and Events
    HealthcareLink